Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICONIC: Ivermectin Combined With Immune-Checkpoint Inhibition in Cancer
NCT07487805Phase 2Not yet recruiting
- Sponsor
- University of Florida
- Start
- Dec 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of CHILD-IVITAB in solid tumor, sponsored by University of Florida. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
CHILD-IVITAB
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07487805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07487805.